Capital Expenditures for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current capital expenditures (TTM) is $125.88M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingCapital ExpendituresSwitch metric
Latest period
$125.88M
YoY change
-21.8%
5Y CAGR
-3.2%
Peak year (2022)
$156.04M
Cumulative capital expenditures
$2.04B
CapEx history chart for ResMed (RMD) from 1993 to 2025
CapEx history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $89.86M | -21.8% | ||
| 2024 | $114.86M | -14.3% | ||
| 2023 | $134.00M | -14.1% | ||
| 2022 | $156.04M | +33.6% | ||
| 2021 | $116.83M | +10.3% | ||
| 2020 | $105.94M | +37.0% | ||
| 2019 | $77.34M | +8.2% | ||
| 2018 | $71.46M | -0.0% | ||
| 2017 | $71.48M | +5.4% | ||
| 2016 | $67.83M | -5.7% | ||
| 2015 | $71.94M | -11.4% | ||
| 2014 | $81.16M | +13.1% | ||
| 2013 | $71.78M | +17.5% | ||
| 2012 | $61.11M | -18.5% | ||
| 2011 | $75.00M | +21.7% | ||
| 2010 | $61.64M | -46.0% | ||
| 2009 | $114.22M | +50.7% | ||
| 2008 | $75.78M | -2.3% | ||
| 2007 | $77.56M | -24.5% | ||
| 2006 | $102.75M | +158.9% | ||
| 2005 | $39.69M | -30.7% | ||
| 2004 | $57.25M | +123.3% | ||
| 2003 | $25.64M | -9.0% | ||
| 2002 | $28.18M | +2.6% | ||
| 2001 | $27.46M | +69.8% | ||
| 2000 | $16.17M | -28.1% | ||
| 1999 | $22.50M | +90.7% | ||
| 1998 | $11.80M | +195.0% | ||
| 1997 | $4.00M | +166.7% | ||
| 1996 | $1.50M | -16.7% | ||
| 1995 | $1.80M | +500.0% | ||
| 1994 | $300,000 | 0.0% | ||
| 1993 | $300,000 | — |
CapEx values are taken from ResMed's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual capital expenditures for ResMed (RMD) came in at $89.86M – declined 21.8% year-over-year.
Through 2020–2025 (5 years), ResMed capital expenditures delivered a -3.2% annualised rate; with a net decline across the window.
Between 2022 and 2025, ResMed capital expenditures plunged 42.4%, falling from $156.04M to $89.86M.
The highest annual capital expenditures of $156.04M was reported in 2022. The lowest in the available history was $300,000 in 1993.
Among 8 Healthcare peers, ResMed (RMD) ranks 9th; the peer median for capital expenditures is $3.87B.
ResMed Capital Expenditures by Year
ResMed Capital Expenditures 2025: $89.86M
ResMed capital expenditures in 2025 was $89.86M, declined 21.8% below 2024.
ResMed Capital Expenditures 2024: $114.86M
ResMed capital expenditures in 2024 was $114.86M, declined 14.3% below 2023.
ResMed Capital Expenditures 2023: $134.00M
ResMed capital expenditures in 2023 was $134.00M, declined 14.1% below 2022.
ResMed Capital Expenditures 2022: $156.04M
ResMed capital expenditures in 2022 was $156.04M, surged 33.6% from 2021. This figure represents the highest annual value in the available history.
ResMed Capital Expenditures 2021: $116.83M
ResMed capital expenditures in 2021 was $116.83M.
See more financial history for ResMed (RMD).
Sector peers — CapEx
Companies in the same sector as ResMed, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is ResMed's capital expenditures?
- Latest reported capital expenditures for ResMed (RMD) is $125.88M (period ending December 31, 2025).
How has ResMed capital expenditures changed year-over-year?
- ResMed (RMD) capital expenditures changed -21.8% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed capital expenditures?
- ResMed (RMD) capital expenditures compound annual growth rate is -3.2% over the most recent 5 years available.
When did ResMed capital expenditures hit its highest annual value?
- ResMed capital expenditures reached its highest annual value of $156.04M in 2022.
What was ResMed capital expenditures in 2024?
- ResMed (RMD) capital expenditures in 2024 was $114.86M.
What was ResMed capital expenditures in 2025?
- ResMed (RMD) capital expenditures in 2025 was $89.86M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.